In Brief: Mosaic Gains Two Clinical-Stage Oncology Assets From Astex

With This In-Licensing, Mosaic Evolves Into A Clinical-Stage Oncology Player

Cancer Cells
The two small molecule assets from Astex are ASTX029 and ASTX295. (Shutterstock)

More from Deals

More from Therapy Areas